Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...

The University of Oxford's study, titled "From Gridlock to Growth: How Leadership Enables India’s PRAGATI Ecosystem to Power Progress," commended the platform’s efficiency in expediting ...